58 Results for "

MAGE

" in MedChemExpress (MCE) Product Catalog:
Products (58)

58 Results for "MAGE" in MCE Product Catalog:

Cat. No.: HY-107582
CAS No.: 1354359-53-7
Purity:  99.54%
Research Areas:  

Cancer

JW480 is a selective KIAA1363/AADACL1 inhibitor with oral activity, featuring IC50 values of 12 nM against human KIAA1363, 20 nM against mouse KIAA1363. JW480 blocks lipid deacetylase activity to restrain HAG metabolism and lowers retinyl ester hydrolase function in hepatic stellate cells. JW480 reduces MAGE lipid levels and inhibits migration, invasion, survival and tumor growth of prostate cancer cells. JW480 lowers PKCδ phosphorylation, facilitates HAGP accumulation, diminishes platelet aggregation, dense granule secretion and Ca 2+ flux, delays arterial thrombosis and prolongs tail bleeding time in rats. JW480 can be used for the study of prostate cancer and thrombosis .
loading...
    loading...
Cat. No.: HY-169087
CAS No.: 3057446-77-9
Research Areas:  

Cancer

MJBIA9836 is a MAGE-A3 ligand with a Kd of approximately 8.1 μM. MJBIA9836 elevates MAGE-A3 levels in MAGE-A3-positive cells. MJBIA9836 serves as a Ligand for Target Protein for PROTAC for the synthesis of MAGE-A3 PROTAC degraders, such as KL-465 (HY-169086). MJBIA9836 can be used in the research of MAGE-A3-positive cancers .
loading...
    loading...
Cat. No.: HY-169086
CAS No.: 3057446-82-6
Target:  

PROTACs

Research Areas:  

Cancer

KL-465 is a MAGE-A3 PROTAC degrader that degrades MAGE-A3 in HeLa cells with a DC50 of 2 μM. KL-465 inhibits the proliferation of MAGE-A3-positive cancer cells. KL-465 can be used for the research of MAGE-A3-related cancers .
loading...
    loading...
Cat. No.: HY-P3640
CAS No.: 178243-46-4
Target:  

Peptides

Research Areas:  

Cancer

MAGE-3 Antigen (167-176) (human) is a polypeptide containing eight amino acids. MAGE-3 Antigen (167-176) (human) is a human leukocyte antigen HLA-B44 molecules epitope encoded by melanoma antigen gene (MAGE) .
loading...
    loading...
Cat. No.: HY-P10491
CAS No.: 252875-61-9
Target:  

Peptides

Research Areas:  

Cancer

MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. MAGE A4 (230-239) is an immunogenic epitope that can activate T cells and trigger the killing of tumor cells expressing MAGE-A4. MAGE A4 (230-239) is used in the development of next-generation T cell-based immunotherapies .
loading...
    loading...
Cat. No.: HY-P10263
CAS No.: 144449-86-5
Synonyms: MAGE-1(161-169), human
Target:  

Peptides

Research Areas:  

Others

MAGE-1 nonapeptide (MAGE-1 (161-169), human) is a radioiodinated photoreactive derivative from MAGE-1 encoded melanoma tumor antigen .
loading...
    loading...
Cat. No.: HY-P10264
CAS No.: 154652-68-3
Synonyms: MAGE-3(168-176), human
Target:  

Peptides

Research Areas:  

Cancer

MAGE-3 peptide (MAGE-3 168-176, human) is a peptide encoded by human MAGE-3 gene, which is expressed in tumor cells, presented by HLA and recognized by cytolytic T lymphocytes (CTL) as tumor antigen .
loading...
    loading...
Cat. No.: HY-P2524
CAS No.: 160295-81-8
Target:  

Peptides

Research Areas:  

Cancer

MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta .
loading...
    loading...
Cat. No.: HY-149452
CAS No.: 2758867-71-7
Research Areas:  

Cancer

SJ1008066 is a MAGE-A11 inhibitor with anIC50 of 0.13 μM. SJ 1008066 binds to the MAGE homology domain (MHD) and disrupts MAGE-A11:PCF11 interaction .
loading...
    loading...
Cat. No.: HY-P10496A
Target:  

Peptides

Research Areas:  

Cancer

MAGE-A1-derived peptide acetate is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide acetate can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide acetate can be used in the study of tumor immunity .
loading...
    loading...
Cat. No.: HY-P10496
CAS No.: 160213-30-9
Target:  

Peptides

Research Areas:  

Cancer

MAGE-A1-derived peptide is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide can be used in the study of tumor immunity .
loading...
    loading...
Cat. No.: HY-P1842
CAS No.: 171066-85-6
Target:  

Peptides

Research Areas:  

Cancer

MAGE-A3 (195-203) is a human leukocyte antigen (HLA) -A24 molecules epitope encoded by melanoma antigen gene (MAGE) .
loading...
    loading...
Cat. No.: HY-165025
CAS No.: 112014-15-0
2-thioacetyl MAGE is a colorimetric substrate of a serine hydrolase enzyme KIAA1363 .
loading...
    loading...
Cat. No.: HY-114056
CAS No.: 926657-43-4
Target:  

Others

Research Areas:  

Cancer

AS115 is a potent and selective KIAA1363 inactivator with IC50 value of 150 nM. KIAA1363 is a 2-acetyl monoacylglycerol ether (MAGE) hydrolase that is upregulated in aggressive cancers of various tissues .
loading...
    loading...
Cat. No.: HY-P990603
Synonyms: RG-6290

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

IMC-C103C is a human antibody expressed in CHO cells, targeting MAGE-A4. IMC-C103C contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for IMC-C103C can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P11129
CAS No.: 289905-22-2
Target:  

Peptides

Research Areas:  

Cancer

MAGE-A4 (286-294) is a polypeptide derived from the 286th to 294th amino acids of the MAGE-A4 protein. MAGE-A4 (286-294) binds HLA-­A*02 with an affinity of 560.08 nM and an IC50 of 8.52 nM. MAGE-A4 (286-294) can be detected in various types of cancers (such as esophageal cancer, lung squamous cell carcinoma, bladder cancer). MAGE-A4 (286-294) can be used to produce CAR-T cells and to develop CAR-T cell therapy .
loading...
    loading...
Cat. No.: HY-P11621A
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

JWP24 acetate is the first cell membrane-permeable peptide inhibitor of MAGE-A4, with an IC50 of 200 nM against human MAGE-A4. JWP24 acetate binds to intracellular targets while retaining binding activity, disrupts the interaction between MAGE-A4 and RAD18, and does not induce cytotoxicity at effective concentrations. JWP24 acetate is applicable for cancer-related research .
loading...
    loading...
Cat. No.: HY-P11621
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

JWP24 is the first cell membrane-permeable peptide inhibitor of MAGE-A4, with an IC50 of 200 nM against human MAGE-A4. JWP24 binds to intracellular targets while retaining binding activity, disrupts the interaction between MAGE-A4 and RAD18, and does not induce cytotoxicity at effective concentrations. JWP24 is applicable for cancer-related research .
loading...
    loading...
Cat. No.: HY-P84325
Synonyms: CT1.4; MAGE4; MAGE4A; MAGE4B; MAGE-41; MAGE-X2

Host:  

Mouse

Application:  

WB, IHC-P, FC, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88116
Synonyms: CT1.4; MAGE-41; MAGE-X2; MAGE4; MAGE4A; MAGE4B

Host:  

Mouse

Application:  

WB, IHC-P, FC

Reactivity:  

Human

loading...
    loading...